Neuroscience and Neuroengineering Research Center, Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Curr Drug Targets. 2019;20(7):748-755. doi: 10.2174/1389450120666190214115309.
Brain edema primarily occurs as a consequence of various cerebral injuries including ischemic stroke. Excessive accumulation of brain water content causes a gradual expansion of brain parenchyma, decreased blood flow and increased intracranial pressure and, ultimately, cerebral herniation and death. Current clinical treatment for ischemic edema is very limited, therefore, it is urgent to develop novel treatment strategies. Mounting evidence has demonstrated that AQP4, a water channel protein, is closely correlated with brain edema and could be an optimal therapeutic target for the reduction of ischemic brain edema. AQP4 is prevalently distributed in the central nervous system, and mainly regulates water flux in brain cells under normal and pathological conditions. This review focuses on the underlying mechanisms of AQP4 related to its dual role in edema formation and elimination.
脑水肿主要发生在各种脑损伤后,包括缺血性脑卒中。脑水含量过度积聚导致脑实质逐渐扩张、血流减少和颅内压增高,最终导致脑疝和死亡。目前缺血性水肿的临床治疗方法非常有限,因此,迫切需要开发新的治疗策略。越来越多的证据表明,水通道蛋白 AQP4 与脑水肿密切相关,可能是减轻缺血性脑水肿的最佳治疗靶点。AQP4 广泛分布于中枢神经系统,主要调节正常和病理条件下脑细胞内的水通量。本综述重点讨论了 AQP4 与水肿形成和消退的双重作用相关的潜在机制。